WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001030837) A NOVEL POLYPEPTIDE - HUMAN GALECTIN 15 AND A POLYNUCLEOTIDE ENCODING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/030837    International Application No.:    PCT/CN2000/000376
Publication Date: 03.05.2001 International Filing Date: 27.10.2000
Chapter 2 Demand Filed:    21.05.2001    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: SHANGHAI BIO ROAD GENE DEVELOPMENT LTD. [CN/CN]; 12th Floor, 3rd Building, 1111 Zhongshan Bei Er Road, Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI ZHI XIN PATENT AGENT LTD.; 10/F, Italy Building, 446 Zhao Jia Bang Road, Shanghai 200031 (CN)
Priority Data:
99 1 19900.6 28.10.1999 CN
Title (EN) A NOVEL POLYPEPTIDE - HUMAN GALECTIN 15 AND A POLYNUCLEOTIDE ENCODING THE SAME
(FR) NOUVEAU POLYPEPTIDE, GALECTINE 15, ET POLYNUCLEOTIDE CODANT POUR CE POLYPEPTIDE
Abstract: front page image
(EN)The present invention discloses a novel polypeptide - human galectin 15 and a polynucleotide encoding the same, as well as a method of producing the polypeptide by DNA recombinant technology. The present invention also discloses methods of using the polypeptide in treatment of various diseases, such as malignant tumor, blood disease, HIV infection, immunological disease and various type inflammation. The present invention also discloses an antagonist against the polypeptide and the therapeutic use of the game. The present invention also discloses the use of such polynucleotide encoding human galectin 15.
(FR)L'invention concerne un nouveau polypeptide, une galectine 15, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la galectine 15.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)